In order to investigate the role of ANRIL in atherosclerosis exclusively, the study was conducted on hypertensive patients (diastolic blood pressure of ≥ 90 mmHg and/or systolic blood pressure of ≥ 140 mmHg32). The gene discussed is CDKN2B-AS1; the disease is atherosclerosis.